tiprankstipranks
Trending News
More News >
Lifeist Wellness (TSE:LFST)
:LFST

Lifeist Wellness (LFST) AI Stock Analysis

Compare
245 Followers

Top Page

TS

Lifeist Wellness

(OTC:LFST)

Rating:45Neutral
Price Target:
Lifeist Wellness faces significant financial hurdles, with ongoing losses and a shrinking asset base posing risks to its long-term viability. Despite the bearish technical indicators and challenging valuation, recent strategic initiatives aimed at revitalizing growth provide some optimism. The high volatility and lack of profitability, however, warrant caution for potential investors.

Lifeist Wellness (LFST) vs. iShares MSCI Canada ETF (EWC)

Lifeist Wellness Business Overview & Revenue Model

Company DescriptionLifeist Wellness Inc. operates as a wellness company in the United States and Canada. The company operates CannMart.com, an online marketplace for hemp-derived CBD and accessories; and Findify, an artificial intelligence powered technology platform that offers personalized search, recommendations, and advanced data analytics for B2B ecommerce customers, as well as a butane hash oil extraction facility. It also distributes licensed and in-house branded adult-use cannabis and cannabis derived products; and supplies hardware, including vaporizers and related accessories, as well as engages in the biosciences and consumer wellness business. The company was formerly known as Namaste Technologies Inc. and changed its name to Lifeist Wellness Inc. in September 2021. Lifeist Wellness Inc. was incorporated in 2005 and is based in Vancouver, Canada.
How the Company Makes MoneyLifeist Wellness generates revenue through multiple streams. The company earns money by selling its diverse product line, which includes cannabis products, wellness technology devices, and nutraceuticals, directly to consumers through its e-commerce platforms. Additionally, Lifeist partners with various retail and distribution networks to expand its market reach. The company also explores strategic partnerships and collaborations to enhance its product offerings and tap into new markets, contributing to its revenue growth. Furthermore, Lifeist invests in research and development to innovate and introduce new products, which helps maintain a competitive edge and drive sales.

Lifeist Wellness Financial Statement Overview

Summary
Lifeist Wellness is facing significant financial challenges, characterized by declining revenues and consistent losses. While the company benefits from having no debt, its negative cash flows and shrinking asset base pose risks to long-term sustainability. Improvements in cash management will be crucial for future stability.
Income Statement
25
Negative
The company has consistently reported negative net income and EBIT over the past years, indicating ongoing profitability challenges. Revenue has also shown a declining trend from 2020 to 2024, with significant drops in the most recent year. Gross Profit Margin has improved slightly, but overall profitability remains weak.
Balance Sheet
40
Negative
The company has a strong equity position with no debt as of the latest report, which is positive. However, the overall asset base has decreased significantly over the years, and the equity ratio has declined, suggesting a shrinking balance sheet. Return on Equity remains negative due to ongoing losses.
Cash Flow
30
Negative
Operating cash flows have been negative, reflecting challenges in generating cash from core operations. Free cash flow has also been consistently negative, indicating potential liquidity issues. However, the recent year showed some improvement in operating cash flow compared to prior periods.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.13M588.80K21.66M22.07M21.15M25.10M
Gross Profit-2.44M204.75K5.34M3.79M120.29K1.46M
EBITDA-4.78M-3.99M-5.96M-17.44M-20.25M-24.01M
Net Income-358.05K-1.45M-14.13M-15.44M-23.80M-26.25M
Balance Sheet
Total Assets3.45M5.13M13.40M20.67M37.96M39.23M
Cash, Cash Equivalents and Short-Term Investments1.60M2.34M1.45M3.80M12.74M10.28M
Total Debt0.000.001.27M328.33K554.59K755.32K
Total Liabilities744.78K1.06M9.94M7.30M11.89M10.24M
Stockholders Equity2.71M4.07M3.46M13.36M26.06M29.25M
Cash Flow
Free Cash Flow-2.54M-877.20K-2.79M-16.04M-18.64M-27.98M
Operating Cash Flow-2.54M-877.20K-2.46M-15.35M-18.28M-24.54M
Investing Cash Flow2.44M1.92M1.28K6.69M-229.57K-2.70M
Financing Cash Flow45.16K-169.19K83.82K-252.29K21.02M-284.24K

Lifeist Wellness Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.13
Price Trends
50DMA
0.07
Positive
100DMA
0.06
Positive
200DMA
0.06
Positive
Market Momentum
MACD
0.01
Negative
RSI
73.22
Negative
STOCH
75.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.07, and above the 200-day MA of 0.06, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 73.22 is Negative, neither overbought nor oversold. The STOCH value of 75.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:LFST.

Lifeist Wellness Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
$7.49B0.22-61.87%2.28%16.62%1.08%
45
Neutral
$4.74M4.06%-70.34%82.73%
TSWIB
C$1.96M
$1.27M
C$1.43M
39
Underperform
C$895.53K-178.36%0.89%-179.36%
TSPBF
35
Underperform
C$2.12M271.59%12.21%53.87%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:LFST
Lifeist Wellness
0.15
0.03
26.09%
TSE:WIB
West Island Brands Inc
0.13
0.00
0.00%
STMH
Stem Holdings
0.01
-0.02
-66.67%
TSE:SILO
Silo Wellness Inc
0.01
0.00
0.00%
TSE:XTRX
Adastra Labs Holdings Ltd.
0.16
-1.14
-87.69%
TSE:PBF
Planet Based Foods Global Inc
0.10
0.03
42.86%

Lifeist Wellness Corporate Events

Product-Related AnnouncementsBusiness Operations and Strategy
Lifeist Wellness Relaunches Mikra with New Digital Strategy and Product Line
Positive
Apr 24, 2025

Lifeist Wellness Inc. has relaunched its Mikra brand with a new e-commerce website, refreshed branding, and a digital strategy aimed at driving revenue growth. The relaunch includes the introduction of three new products and a reformulated best-seller, designed to support brain health, hydration, and emotional well-being. The company has partnered with a digital design firm to enhance its online presence, implementing features such as subscription-driven growth, smart email automation, and a data-driven paid media overhaul. This strategic move is expected to enhance customer engagement, increase sales, and position Lifeist for scalable growth in the wellness industry.

Spark’s Take on TSE:LFST Stock

According to Spark, TipRanks’ AI Analyst, TSE:LFST is a Underperform.

Lifeist Wellness faces significant financial hurdles with ongoing losses and declining revenue. Despite no debt, the company’s shrinking asset base and negative cash flows raise concerns. Technical indicators show a mixed picture with some bullish signals but overall bearish trend. Recent strategic initiatives provide a positive outlook, yet the challenging valuation and high volatility warrant caution.

To see Spark’s full report on TSE:LFST stock, click here.

Product-Related AnnouncementsBusiness Operations and Strategy
Lifeist Wellness Announces Strategic Overhaul and Expansion for Mikra
Positive
Apr 1, 2025

Lifeist Wellness Inc. is set to unveil a major brand refresh and product expansion for its subsidiary, Mikra Cellular Sciences Inc., emphasizing new collaborations and a focus on cognitive health. The strategic overhaul includes a complete brand refresh, optimization of Mikra’s business model, and expansion into the electrolyte category, positioning Mikra for sustainable growth and reinforcing its role as a high-growth asset within Lifeist’s portfolio. This transformation aims to enhance Mikra’s market position, optimize operations, and drive long-term revenue growth, with new products and collaborations set to launch in April 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 02, 2025